25,387 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Bought by Intech Investment Management LLC

Intech Investment Management LLC bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 25,387 shares of the company’s stock, valued at approximately $462,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PRVA. Millennium Management LLC boosted its stake in shares of Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after purchasing an additional 1,101,730 shares during the last quarter. BlackBarn Capital Partners LP raised its stake in Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock worth $6,952,000 after buying an additional 200,000 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Privia Health Group by 18.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after buying an additional 173,934 shares during the period. Victory Capital Management Inc. boosted its position in Privia Health Group by 402.9% during the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after acquiring an additional 143,446 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in Privia Health Group during the 2nd quarter worth about $1,121,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Stock Up 3.9 %

Shares of NASDAQ:PRVA opened at $22.31 on Tuesday. The stock has a market cap of $2.68 billion, a price-to-earnings ratio of 215.60, a PEG ratio of 5.40 and a beta of 0.76. The business’s 50 day moving average is $19.24 and its 200 day moving average is $18.71. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $24.30.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on PRVA shares. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price objective on shares of Privia Health Group in a research note on Wednesday, August 14th. Truist Financial increased their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday. Robert W. Baird increased their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 26th. Finally, KeyCorp initiated coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target for the company. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $24.93.

Insider Transactions at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This trade represents a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.20% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.